Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
March 3, 2025 1:12 PM 2 min read

Microsoft Unveils AI-Powered Dragon Copilot To Ease Clinician Workloads

by Vandana Singh Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

Microsoft Corp (NASDAQ:MSFT) is launching Dragon Copilot, an AI assistant designed to streamline clinical workflows by combining voice dictation, ambient listening, and generative AI.

Built as part of Microsoft Cloud for Healthcare, the tool aims to reduce administrative burdens and enhance patient care.

Joe Petro, corporate vice president of Microsoft Health and Life Sciences Solutions and Platforms, emphasized AI's role in reducing administrative tasks for clinicians. "With Dragon Copilot, we are introducing the first unified voice AI experience, leveraging our decades-long expertise to improve provider wellness and financial outcomes," he said.

Also Read: SoundHound AI’s CEO On AI Agents Transforming The World: ‘This Is An Inevitable Evolution’

Dr. R. Hal Baker, senior vice president and chief digital officer at WellSpan Health, highlighted how Dragon Copilot integrates into Microsoft's AI ecosystem to enhance patient experiences while streamlining clinician workflows. "It's a game-changer," he said.

The AI assistant builds on the success of Microsoft's Dragon Medical One (DMO) and Dragon Ambient eXperience (DAX).

In the past month alone, DAX has facilitated over 3 million ambient patient conversations across 600 healthcare organizations.

Clinicians using these technologies report saving five minutes per patient encounter, with 70% experiencing reduced burnout and 62% less likely to leave their jobs. Meanwhile, 93% of patients have reported an improved overall experience.

Dragon Copilot offers key features such as:

  • Streamlined Documentation: Automated note-taking, speech recognition and personalized text formatting in multiple languages.
  • Information Retrieval: AI-powered medical searches from trusted sources.
  • Task Automation: AI-generated referral letters, clinical summaries and after-visit notes.

Dragon Copilot is designed for use in ambulatory, inpatient and emergency care settings.

It will be available in the U.S. and Canada in May, with expansion to the U.K., Germany, France and the Netherlands. Microsoft also plans to introduce Dragon Copilot to additional global markets.

Price Action: MSFT stock is down 0.65% at $394.42 at the last check Monday.

Read Next:

  • Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy

Image: Microsoft Dragon Copilot logo

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Large CapNewsHealth CareTechGeneralartificial intelligenceBriefs
MSFT Logo
MSFTMicrosoft Corp
$405.09-0.95%
Overview
MSFT Logo
MSFTMicrosoft Corp
$405.09-0.95%
Overview
Comments
Loading...